Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1PUJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,581
Award facts
- Contract value 100% obligated
- $1,580.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,580.52 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injections on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. The company has demonstrated substantial capacity to fulfill federal requirements through its extensive contract portfolio with DLA, which historically covers diabetes medications, neurological treatments, pain management pharmaceuticals, vaccines, and specialized medical supplies. This award for Mounjaro, a GLP-1 receptor agonist used in diabetes and weight management treatment, reflects the company's continued role in supplying specialized pharmaceutical products essential to military medical readiness and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1PUJ?
SPE2DR26F1PUJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F1PUJ worth?
The government has obligated $1,581 on SPE2DR26F1PUJ.
Is contract SPE2DR26F1PUJ an order under another contract?
Yes. SPE2DR26F1PUJ is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1PUJ competed?
The extent of competition for SPE2DR26F1PUJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award